Is Moderna, Inc. overvalued?

Moderna, Inc. (MRNA) — key valuation metrics and fundamentals.

No verdict

Price

$223.37

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$90.38B

Dividend yield

0.0%

Return on equity

-37.6%

Sector

Healthcare

Fair value compares MRNA's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.

Related stocks